Skip to main content
. 2013 Aug 23;27(11):943–953. doi: 10.1007/s40263-013-0102-x

Fig. 3.

Fig. 3

Matching-adjusted indirect comparison of change from baseline at final on-treatment assessment in ADHD-RS-IV scores: three-trial base case and sensitivity analyses. ADHD attention-deficit/hyperactivity disorder, ADHD-RS-IV ADHD Rating Scale IV, ATX atomoxetine, GXR guanfacine extended release, SE standard error. *p < 0.05 compared with ATX. **p < 0.01 compared with ATX